TOPICS

Tag: Psoriasis

Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study

J Clin Aesthet Dermatol. 2022;15(1):53–58. by Ulrich Mrowietz, MD; Leon Kircik, MD; Kristian Reich, MD; Sagar Munjal, MD, MS; Srinivas Shenoy, MD; and Mark Lebwohl, MD Dr. Mrowietz is with the Psoriasis Center at the Department of Dermatology at the University Medical Center Schleswig-Holstein in Campus Kiel, Germany. Dr. Kircik is with DermResearch, PLLC, in

CONTINUE READING »

Utility and Limitations of Transient Elastography to Monitor Hepatic Steatosis, Hepatic Fibrosis, and Methotrexate-Associated Hepatic Disease in Psoriasis: A Systematic Review

J Clin Aesthet Dermatol. 2021;14(12):24-28. by Rachel L. Marsh, MD; Sean Kelly, MD; Khalid Mumtaz, MBBS; and Jessica Kaffenberger, MD Drs. Marsh and Kaffenberger are with the Dpartment of Internal Medicine, Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio. Drs. Kelly and Mumtaz are with the Department of Internal

CONTINUE READING »

Review on Novel Oral Therapies for Psoriasis

J Clin Aesthet Dermatol. 2021;14(12):55–63. by Olga Marushchak, MA; Rose Yakubov, BHSc (Candidate); Rebecca Yakubov, BHSc (Candidate); and Gary Goldenberg, MD Ms. Marushchak and Dr. Goldenberg are with the  Icahn School of Medicine at Mount Sinai in New York, New York. Ms. Rose Yakubov and Ms. Rebecca Yakubov are with McMaster University in Hamilton, Ontario,

CONTINUE READING »